OBJECTIVE: To evaluate the equivalence of ceftriaxone plus doxycycline or azithromycin for
cases of mild pelvic inflammatory disease (PID). METHODS: Patients with PID received an …

Background Anaerobic organisms are important pathogens in acute pelvic inflammatory
disease (PID). The currently recommended PID regimen of a single dose of ceftriaxone and …

Objective: In the United Kingdom many genitourinary medicine clinics use oral doxycycline
and metronidazole to treat pelvic inflammatory disease (PID). A retrospective case note …

Objective To assess the effectiveness and safety of antibiotic regimens used to treat pelvic
inflammatory disease (PID). Design This is a systematic review and meta-analysis of …

This multicenter, prospective, double-blind study compared the safety and efficacy of
clindamycin and ciprofloxacin versus ceftriaxone and doxycycline in the treatment of …

Pelvic inflammatory disease (PID) is one of the most common serious infections of
nonpregnant women of reproductive age. Management of PID is directed at containment of …

Objective: Pelvic inflammatory disease (PID) is a common and morbid intraperitoneal
infection. Although most women with pelvic inflammatory disease are treated as outpatients …

Please cite this paper as: Judlin P, Liao Q, Liu Z, Reimnitz P, Hampel B, Arvis P. Efficacy and
safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study …

Pelvic inflammatory disease (PID) is a gynaecological inflammatory disorder with a high
incidence that can lead to sequelae such as infertility, ectopic pregnancy and chronic pelvic …

This multicentre, double-blind study was undertaken to demonstrate non-inferiority of once-
daily oral moxifloxacin compared with combination therapy in the management of acute …